Roivant Sciences Total Current Assets increased by 10.9% to $5.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $5.00B to $5.17B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 18.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.06B | $2.56B | $2.29B | $2.15B | $2.04B | $1.71B | $1.65B | $1.80B | $1.56B | $1.55B | $6.81B | $6.73B | $6.00B | $5.80B | $5.36B | $5.00B | $4.62B | $4.51B | $4.66B | $5.17B |
| QoQ Change | — | +24.2% | -10.5% | -6.2% | -5.0% | -15.9% | -4.0% | +9.3% | -13.2% | -0.6% | +338.7% | -1.1% | -10.8% | -3.3% | -7.5% | -6.8% | -7.7% | -2.3% | +3.3% | +10.9% |
| YoY Change | — | — | — | — | -0.9% | -32.9% | -28.0% | -16.2% | -23.5% | -9.5% | +313.5% | +274.3% | +284.4% | +273.9% | -21.2% | -25.7% | -23.1% | -22.2% | -13.1% | +3.3% |